Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

293
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

125
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Linezolid Induced Twice Pure Red Cell Aplasia in a Patient with Central Nervous System Infection after Allogeneic Stem Cell Transplantation

Pages

  647-651

Abstract

 Linezolid (LZD), severed as the first Oxazolidinone antibiotic, was active against multidrugresistant gram-positive strains. LZD can induce thrombocytopenia, anemia and leukocytopenia. Currently, reports on Pure red cell aplasia (PRCA) cases induced by LZD are relatively rare (4-7). In this paper, we reported a patient with PRCA twice induced by LZD. A 37-year-old man was diagnosed with myelodysplatic syndrome (MDS) and underwent allo-HSCT from an unrelated donor with ABO blood type and leukocyte antigen (HLA)-matching. After HSCT for 2 years, the patient suffered from refractory fever and headache. He was first treated with empirical antifungal agent and antibiotics for central nervous system (CNS) infection, but then changed to LZD therapy for little effect. Twenty-eight days after LZD treatment, the symptom improved significantly but the hemoglobin declined to 70 g/L and the reticulocyte level was only 0. 23%. The LZD therapy was stopped and the fever and headache symptoms reoccurred 1 week latter. Then, erythropoietin (EPO) and halved dosage of LZD were used for treatment. The CNS infection and the anemia symptom relieved gradually and the level of hemoglobin and reticulocyte declined again. After blood transfusion, the half dose of LZD was sustained without anaemia recovery. In summary, patients with anemia, myelosuppressants history or potential abnormal proliferation of T cells may suffer PRCA with long term LZD treatment. The monitoring of complete blood count and reticulocyte count were necessary during LZD therapy. If the clinical condition permits, LZD dosage reduction and blood transfusion should be considered.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    Hu, Wenqing, SHI, BING, LIU, LIHUI, He, Shengke, Ye, Liping, Tian, DengMei, Zhang, Yongqing, & Zhang, Yongqing. (2016). Linezolid Induced Twice Pure Red Cell Aplasia in a Patient with Central Nervous System Infection after Allogeneic Stem Cell Transplantation. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 15(2), 647-651. SID. https://sid.ir/paper/288630/en

    Vancouver: Copy

    Hu Wenqing, SHI BING, LIU LIHUI, He Shengke, Ye Liping, Tian DengMei, Zhang Yongqing, Zhang Yongqing. Linezolid Induced Twice Pure Red Cell Aplasia in a Patient with Central Nervous System Infection after Allogeneic Stem Cell Transplantation. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2016;15(2):647-651. Available from: https://sid.ir/paper/288630/en

    IEEE: Copy

    Wenqing Hu, BING SHI, LIHUI LIU, Shengke He, Liping Ye, DengMei Tian, Yongqing Zhang, and Yongqing Zhang, “Linezolid Induced Twice Pure Red Cell Aplasia in a Patient with Central Nervous System Infection after Allogeneic Stem Cell Transplantation,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 15, no. 2, pp. 647–651, 2016, [Online]. Available: https://sid.ir/paper/288630/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top